Gerald Carlson

Chief Executive Officer presso Phibro Animal Health (Belgium) SA

81 anni

Process Industries

Health Technology

Government

Profilo

Gerald K.
Carlson is currently the Chief Executive Officer at Phibro Animal Health (Belgium) SA. Previously, he worked as the Chief Operating Officer & Director at Phibro Animal Health Corp.
from 2014 to 2016.
He also worked as the Senior VP-Corporate Planning & Development at Ecolab, Inc. in 1998 and as the Commissioner-Trade & Development at State of Minnesota from 1999 to 2001.

Posizioni attive di Gerald Carlson

Società	Posizione	Inizio
Phibro Animal Health (Belgium) SA Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium	Chief Executive Officer	08/06/2011

Tutte le posizioni attive di Gerald Carlson

Precedenti posizioni note di Gerald Carlson

Società	Posizione	Fine
State of Minnesota	Corporate Officer/Principal	01/01/2001
ECOLAB INC.	Corporate Officer/Principal	01/10/1998
PHIBRO ANIMAL HEALTH CORPORATION	Chief Executive Officer	01/03/2014

Vedi nel dettaglio l'esperienza di Gerald Carlson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gerald Carlson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ECOLAB INC.	Process Industries
PHIBRO ANIMAL HEALTH CORPORATION	Health Technology

Aziende private	2
State of Minnesota	Government
Phibro Animal Health (Belgium) SA Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium	Process Industries